Clearside Biomedical - 53 Year Dividend History | CLSD

Historical dividend payout and yield for Clearside Biomedical (CLSD) since 1971. The current TTM dividend payout for Clearside Biomedical (CLSD) as of May 17, 2024 is $0.00. The current dividend yield for Clearside Biomedical as of May 17, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.098B $0.008B
Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. Clearside Biomedical, Inc. is headquartered in Alpharetta, Georgia.
Stock Name Country Market Cap PE Ratio